Ethyl Tetradecanoate

Ethyl Tetradecanoate

SCHEMBL9210318

CCCCCCCCCCCCCC(=O)OCC.CCCCOC(=O)CCCCCCCC(=O)OCCCC

nearest known ligand 0.77

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.77
DNM1 Q05193 1/20 0.62
NAAA Q02083 1/20 0.59
PRSS1 P07477 1/20 0.58
PRSS2 P07478 1/20 0.58
PRSS3 P35030 1/20 0.58
PAM P19021 2/20 0.58
HTR2C P28335 1/20 0.56
TSHR P16473 1/20 0.55
MAPT P10636 1/20 0.55
CYP1A2 P05177 1/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 1/20 0.53
KDM4E B2RXH2 1/20 0.51
DUSP3 P51452 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10778078 1.00 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL5269137 0.98 DGKA (0.73) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL5271136 0.98 DGKA (0.73) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL20563779 0.98 DGKA (0.73) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL20563407 0.98 DGKA (0.73) DGKADNM1NAAAPRSS1PRSS2
Dibutyl Sebacate SCHEMBL8781029 0.98 DGKA (0.73) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL8781014 0.96 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL8113649 0.96 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
Ethyl Tetradecanoate SCHEMBL7458981 0.96 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2
SCHEMBL21866546 0.96 DGKA (0.77) DGKADNM1NAAAPRSS1PRSS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1995005159-A1 ACYLATED HYDROXYALKANOATES AND THEIR USES UNILEVER PLC (GB) 1995-02-23 WO disclosed